Pituitary tumor-transforming gene in endocrine and other neoplasms: A review and update

Endocrine-Related Cancer

Volumn 15, Issue 3, 2008, Pages 721-743

  Salehi, Fateme ^a   Kovacs, Kalman ^a   Scheithauer, Bernd W ^b   Lloyd, Ricardo V ^b   Cusimano, Michael ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BASIC FIBROBLAST GROWTH FACTOR; BRCA1 PROTEIN; CALCIUM CHANNEL; CYCLOSPORIN A; DNA DEPENDENT PROTEIN KINASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; HYDROCORTISONE; INHIBITOR OF DIFFERENTIATION 3; INSULIN; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; PROTEIN SH3; SECURIN; SMALL INTERFERING RNA; SOMATOMEDIN C; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR PAX8; TRANSCRIPTION FACTOR SP1; UPSTREAM STIMULATORY FACTOR 1; VASCULOTROPIN;

ANEUPLOIDY; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTISENSE THERAPY; APOPTOSIS; BREAST CARCINOMA; CANCER INVASION; CANCER RECURRENCE; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; COLON CARCINOMA; DIABETES MELLITUS; DNA DAMAGE; DNA REPAIR; DRUG TARGETING; ENDOCRINE TUMOR; ESOPHAGUS CARCINOMA; ESTROGEN RELEASE; GENE CONTROL; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE OVEREXPRESSION; GENE STRUCTURE; GENE TRANSLOCATION; GENETIC EPIGENESIS; GENOMIC INSTABILITY; HEAD AND NECK CANCER; HUMAN; HYPERGLYCEMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; LEIOMYOMA; LIVER CELL CARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; NEOPLASM; NONHUMAN; OVARY CARCINOMA; PANCREAS ISLET BETA CELL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RECTUM CARCINOMA; REGULATORY MECHANISM; REVIEW; THYROID CARCINOMA; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; APOPTOSIS; CELL CYCLE; ENDOCRINE GLAND NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; NEUROENDOCRINE TUMORS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; TISSUE DISTRIBUTION;

EID: 53849096004     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-08-0012     Document Type: Review

References (123)

1. Abbud RA, Takumi I, Barker EM, Ren SG, Chen DY. Wawrowsky K & Melmed S 2005 Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Molecular Endocrinology 19 1383-1391.
2. Ai J, Zhang Z, Xin D, Zhu H, Yan Q, Xin Z, Na Y & Guo Y 2004 Identification of over-expressed genes in human renal cell carcinoma by combining suppression subtractive hybridization and cDNA library array. Science in China. Series C, Life Sciences 47 148-157.
3. Akino K, Mineta T, Fukui M, Fujii T & Akita S 2003 Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells. Wound Repair and Regeneration 11 354-360.
4. Akino K, Akita S, Mizuguchi T, Takumi I, Yu R, Wang XY, Rozga J, Demetriou AA, Melmed S, Ohtsuru A et al. 2005 A novel molecular marker of pituitary tumor transforming gene involves in a rat liver regeneration. Journal of Surgical Research 129 142-146.
5. Bae I, Rih JK, Kim HJ, Kang HJ, Haddad B, Kirilyuk A, Fan S, Avantaggiati ML & Rosen EM 2005 BRCA1 regulates gene expression for orderly mitotic progression. Cell Cycle 4 1641-1666.
6. Bernal JA & Hernandez A 2007 p53 stabilization can be uncoupled from its role in transcriptional activation by loss of PTTG1/securin. Journal of Biochemistry 141 737-745.
7. Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F, Arias C, Silva A, Tortolero M & Pintor-Toro JA 2002 Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nature Genetics 32 306-311.
8. Bernal JA, Roche M, Mendez-Vidal C. Espina A, Tortolero M & Pintor-Toro JA 2008 Proliferative potential after DNA damage and non-homologous end joining are affected by loss of securin. Cell Death and Differentiation 15 202-212.
9. Boelaert K, McCabe CJ, Tannahill LA, Gittoes NJ, Holder RL, Watkinson JC, Bradwell AR, Sheppard MC & Franklyn JA 2003a Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism 88 2341-2347.
10. Boelaert K, Tannahill LA, Bulmer JN, Kachilele S, Chan SY, Kim D, Gittoes NJ, Franklyn JA, Kilby MD & McCabe CJ 2003b A potential role for PTTG/securin in the developing human fetal brain. FASEB Journal 17 1631-1639.
11. Boelaert K, Yu R, Tannahill LA, Stratford AL, Khanim FL, Eggo MC, Moore JS, Young LS, Gittoes NJ, Franklyn JA et al. 2004 PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro. Journal of Molecular Endocrinology 33 663-677.
12. Boelaert K, Smith VE, Stratford AL, Kogai T, Tannahill LA, Watkinson JC, Eggo MC, Franklyn JA & McCabe CJ 2007 PTTG and PBF repress the human sodium iodide symporter. Oncogene 26 4344-4356.
13. Chae YM, Park KK, Lee IK, Kim JK, Kim CH & Chang YC 2006 Rmg-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction. Gene Therapy 13 430-439.
14. Chamaon K, Kirches E, Kanakis D, Braeuninger S, Dietzmann K & Mawrin C 2005 Regulation of the pituitary tumor transforming gene by insulin-like-growth factor-I and insulin differs between malignant and non-neoplastic astrocytes. Biochemical and Biophysical Research Communications 331 86-92.
15. Chen L, Puri R, Letkowitz EJ & Kakar SS 2000 Identification of the human pituitary tumor transforming gene (hPTTG) family: molecular structure, expression, and chromosomal localization. Gene 248 41-50.
16. Chen G, Li J, Li F, Li X, Zhou J, Lu Y & Ma D 2004a Inhibitory effects of anti-sense PTTG on malignant phenotype of human ovarian carcinoma cell line SK-OV-3. Journal of Huazhong University of Science and Technology. Medical Sciences 24 369-372.
17. Chen L, Liu YS, Wang LS, Yin HG. Hou QT, Liu ZX, Chen LH & Ling F 2004 b Expression of pituitary tumor transforming gene, endostatin, and basic fibroblast growth factor mRNAs in invasive pituitary adenomas. Zhong Nan Da Xue Xue Boo. Yi Xue Ban 29 651-653.
18. Chen CC, Chang TW, Chen FM, Hou MF, Hung SY, Chong IW, Lee SC, Zhou TH & Lin SR 2006 Combination of multiple mRNA markers (PTTG1, Survivin, UbcH10 and TK1) in the diagnosis of Taiwanese patients with breast cancer by membrane array. Oncology 70 438-446.
19. Chesnokova V, Kovacs K, Castro AV, Zonis S & Melmed S 2005 Pituitary hypoplasia in Pttg-/- mice is protective for Rb+/- pituitary tumorigenesis. Molecular Endocrinology 19 2371-2379.
20. Chesnokova V, Zonis S, Rubinek T, Yu R, Ben-Shlomo A, Kovacs K, Wawrowsky K & Melmed S 2007 Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Research 67 10564-10572.
21. Chien W & Pei L 2000 A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product. Journal of Biological Chemistry 275 19422-19427.
22. Chin SJ, Hsu TS & Chao JI 2006 Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells. Toxicology Letters 167 122-130.
23. Cho-Rok J, Yoo J, Jang YJ, Kim S, Chu IS, Yeom YI, Choi JY & Im DS 2006 Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo. Hepatology 43 1042-1052.
24. Clem AL, Hamid T & Kakar SS 2003 Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells. Gene 322 113-121.
25. Cong J, Wang HY & Zhang CL 2005 Expression and clinical significance of PTTG and b-FGF in acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 13 951-953.
26. Crosby ME, Jacobberger J, Gupta D, Macklis RM & Almasan A 2007 E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma. Oncogene 26 1897-1909.
27. Dominguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M & Pintor-Toro JA 1998 hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene 17 2187-2193.
28. Donangeto I & Melmed S 2005 Pathophysiology of pituitary adenomas. Journal of Endocrinological Investigation 28 100-105.
29. Donangelo I, Gutman S, Horvath E, Kovacs K, Wawrowsky K, Mount M & Melmed S 2006 Pituitary tumor transforming gene overexpression facilitates pituitary tumor development. Endocrinology 147 4781-4791.
30. Filippella M, Galland F. Kujas M, Young J, Faggiano A, Lombardi G, Colao A, Meduri G & Chanson P 2006 Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clinical Endocrinology 65 536-543.
31. Fraenkel M, Caloyeras J, Ren SG & Melmed S 2006 Sex-steroid milieu determines diabetes rescue in pttg-null mice. Journal of Endocrinology 189 519-528.
32. Fujii T, Nomoto S, Koshikawa K, Yatabe Y, Teshigawara O, Mori T, Inoue S, Takeda S & Nakao A 2006 Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology 43 1267-1275.
33. Fujimoto N, Maruyama S & Ito A 1999 Establishment of an estrogen responsive rat pituitary cell sub-line MtT/E-2. Endocrine Journal 46 389-396.
34. Genkai N, Homma J, Sano M, Tanaka R & Yamanaka R 2006 Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients. Oncology Reports 15 1569-1574.
35. Gillingwater TH, Wishart TM, Chen PE, Haley JE, Robertson K, MacDonald SH, Middleton S, Wawrowski K, Shipston MJ, Melmed S et al. 2006 The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. Human Molecular Genetics 15 625-635.
36. Grutzmann R, Pilarsky C, Ammerpohl O, Luttges J, Bohme A, Sipos B, Foerder M, Alldinger I, Jahnke B, Schackert HK et al. 2004 Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 6 611-622.
37. Hamid T & Kakar SS 2004 PTTG/securin activates expression of p53 and modulates its function. Molecular Cancer 3 18.
38. Heaney AP, Horwitz GA, Wang Z, Singson R & Melmed S 1999 Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nature Medicine 5 1317-1321.
39. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M & Melmed S 2000 Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355 716-719.
40. Heaney AP, Nelson V, Fernando M & Horwitz G 2001 Transforming events in thyroid tumorigenesis and their association with follicular lesions. Journal of Clinical Endocrinology and Metabolism 86 5025-5032.
41. Heaney AP, Fernando M & Melmed S 2002 Functional role of estrogen in pituitary tumor pathogenesis. Journal of Clinical Investigation 109 277-283.
42. Honda S, Hayashi M, Kobayashi Y, Ishikawa Y, Nakagawa K & Tsuchiya E 2003 A role for the pituitary tumor-transforming gene in the genesis and progression of nonsmall cell lung carcinomas. Anticancer Research 23 3775-3782.
43. Horwitz GA, Miklovsky I, Heaney AP, Ren SG & Melmed S 2003 Human pituitary tumor-transforming gene (PTTG1) motif suppresses prolactin expression. Molecular Endocrinology 17 600-609.
44. Hunter JA, Skelly RH, Aylwin SJ, Geddes JF, Evanson J, Besser GM, Monson JP & Burrin JM 2003 The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. European Journal of Endocrinology 148 203-211.
45. Ishikawa H, Heaney AP, Yu R, Horwitz GA & Melmed S 2001 Human pituitary tumor-transforming gene induces angiogenesis. Journal of Clinical Endocrinology and Metabolism 86 867-874.
46. Kakar SS 1999 Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG). Gene 240 317-324.
47. Kakar SS & Malik MT 2006 Suppression of lung cancer with siRNA targeting PTTG. International Journal of Oncology 29 387-395.
48. Kanakis D, Kirches E, Mawrin C & Dietzmann K 2003 Promoter mutations are no major cause of PTTG overexpression in pituitary adenomas. Clinical Endocrinology 58 151-155.
49. Karsten SL, Kudo LC, Jackson R, Sabatti C, Kornblum HI & Geschwind DH 2003 Global analysis of gene expression in neural progenitors reveals specific cell-cycle, signaling, and metabolic networks. Developmental Biology 261 165-182.
50. Kho PS, Wang Z, Zhuang L, Li Y, Chew JL, Ng HH, Liu ET & Yu Q 2004 P53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. Journal of Biological Chemistry 279 21183-21192.
51. Kim D, Pemberton H, Stratford AL, Buelaert K, Watkinson JC, Lopes V, Franklyn JA & McCabe CJ 2005 Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells. Oncogene 24 4861-4866.
52. Kim DS, Buchanan MA, Stratford AL, Watkinson JC, Eggo MC, Franklyn JA & McCabe CJ 2006a PTTG promotes a novel VEGF-KDR-ID3 autocrine mitogenic pathway in thyroid cancer. Clinical Otolaryngology 31 246.
53. Kim DS, Franklyn JA, Boelaert K, Eggo MC, Watkinson JC & McCabe CJ 2006b Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway. Journal of Clinical Endocrinology and Metabolism 91 4603-4611.
54. Kim DS, Franklyn JA, Stratford AL, Boelaert K, Watkinson JC, Eggo MC & McCabe CJ 2006c Pituitary tumor-transforming gene regulates multiple downstream angiogenic genes in thyroid cancer. Journal of Clinical Endocrinology and Metabolism 91 1119-1128.
55. Kim CS, Ying H, Willingham MC & Cheng SY 2007a The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer. Carcinogenesis 28 932-939.
56. Kim DS, Fong J, Read ML & McCabe CJ 2007b The emerging role of pituitary tumour transforming gene (PTTG) in endocrine tumourigenesis. Molecular and Cellular Endocrinology 278 1-6.
57. Kim DS, Franklyn JA, Smith VE, Stratford AL, Pemberton HN, Warfield A, Watkinson JC, Ishmail T, Wakelam MJ & McCabe CJ 2007c Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis 28 749-759.
58. Lai Y, Xin D, Bai J, Mao Z & Na Y 2007 The important antiapoptotic role and its regulation mechanism of PTTG1 in UV-induced apoptosis. Journal of Biochemistry and Molecular Biology 40 966-972.
59. Li S, Huang S & Peng SB 2005 Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. International Journal of Oncology 27 1329-1339.
60. Lo YL, Yu JC, Chen ST, Hsu GC, Mau YC, Yang SL, Wu PE & Shen CY 2007 Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility. Carcinogenesis 28 1079-1086.
61. Malik MT & Kakar SS 2006 Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2). Molecular Cancer 5 61.
62. McCabe CJ & Gittoes NJ 1999 PTTG - a new pituitary tumour transforming gene. Journal of Endocrinology 162 163-166.
63. McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA & Gittoes NJ 2002 Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. Journal of Clinical Endocrinology and Metabolism 87 4238-4244.
64. McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC, Franklyn JA et al. 2003 Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clinical Endocrinology 58 141-150.
65. Mei J, Huang X & Zhang P 2001 Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts. Current Biology 11 1197-1201.
66. Minematsu T, Suzuki M, Sanno N, Takekoshi S, Teramoto A & Osamura RY 2006 PTTG overexpression is correlated with angiogenesis in human pituitary adenomas. Endocrine Pathology 17 143-153.
67. Minematsu T, Egashira N, Kajiya H, Takei M, Takekoshi S, Itoh Y, Tsukamoto H, Itoh J, Sanno N, Teramoto A et al. 2007 PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines. Endocrine Pathology 18 8-15.
68. Mu YM, Oba K, Yanase T, Ito T, Ashida K, Goto K, Morinaga H, Ikuyama S, Takayanagi R & Nawata H 2003 Human pituitary tumor transforming gene (hPTTG) inhibits human lung cancer A549 cell growth through activation of p21(WAF1/CIP1). Endocrine Journal 50 771-781.
69. Ogbagabriel S, Fernando M, Waldman FM, Bose S & Heaney AP 2005 Securin is overexpressed in breast cancer. Modern Pathology 18 985-990.
70. Pei L 1998 Genomic organization and identification of an enhancer element containing binding sites for multiple proteins in rat pituitary tumor-transforming gene. Journal of Biological Chemistry 273 5219-5225.
71. Pei L 1999 Pituitary tumor-transforming gene protein associates with ribosomal protein S10 and a novel human homologue of DnaJ in testicular cells. Journal of Biological Chemistry 274 3151-3158.
72. Pei L 2000 Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function. Journal of Biological Chemistry 275 31191-31198.
73. Pei L 2001 Identification of c-myc as a down-stream target for pituitary tumor-transforming gene. Journal of Biological Chemistry 276 8484-8491.
74. Pei L & Melmed S 1997 Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Molecular Endocrinology 11 433-441.
75. Pemberton HN, Franklyn JA, Boelaert K, Chan SY, Kim DS, Kim C, Cheng SY, Kilby MD & McCabe CJ 2007 Separase, securin and Rad21 in neural cell growth. Journal of Cellular Physio1ogy 213 45-53.
76. Prezant TR, Kadioglu P & Melmed S 1999 An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTTG family. Journal of Clinical Endocrinology and Metabolism 84 1149-1152.
77. Puri R, Tousson A, Chen L & Kakar SS 2001 Molecular cloning of pituitary tumor transforming gene 1 from ovarian tumors and its expression in tumors. Cancer Letters 163 131-139.
78. Rajamannan NM, Subramaniam M, Abraham TP, Vasile VC, Ackerman MJ, Monroe DG, Chew TL & Spelsberg TC 2007 TGFβ inducible early gene-1 (TIEG1) and cardiac hypertrophy: discovery and characterization of a novel signaling pathway. Journal of Cellular Biochemistry 100 315-325.
79. Ramos-Morales F, Dominguez A, Romero F, Luna R, Multon MC, Pintor-Toro JA & Tortolero M 2000 Cell cycle regulated expression and phosphorylation of hpttg protooncogene product. Oncogene 19 403-409.
80. Rehfeld N, Geddert H, Atamna A, Rohrbeck A, Garcia G, Kliszewski S, Neukirchen J, Bruns I, Steidl U, Fenk R et al. 2006 The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer. Journal of Carcinogenesis 5 4.
81. Romero F, Multon MC, Ramos-Morales F, Dominguez A, Bernal JA, Pintor-Toro JA & Tortolero M 2001 Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. Nucleic Acids Research 29 1300-1307.
82. Rubinek T, Chesnokova V, Wolf I, Wawrowsky K, Vlotides G & Melmed S 2007 Discordant proliferation and differentiation in pituitary tumor-transforming gene-null bone marrow stem cells. American Journal of Physiology. Cell Physiology 293 C1082-C1092.
83. Saez C, Japon MA, Ramos-Morales F, Romero F, Segura DI, Tortolero M & Pintor-Toro JA 1999 Hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 18 5473-5476.
84. Saez C, Pereda T, Borrero JJ, Espina A, Romero F, Tortolero M, Pintor-Toro JA, Segura DI & Japon MA 2002 Expression of hpttg proto-oncogene in lymphoid neoplasias. Oncogene 21 8173-8177.
85. Sato F, Abraham JM, Yin J, Kan T, Ito T, Mori Y, Hamilton JP. Jin Z, Cheng Y, Patin B et al. 2006 Polo-like kinase and survivin are esophageal tumor-specific promoters. Biochemical and Biophysical Research Communications 342 465-471.
86. Shibata Y, Haruki N, Kuwabara Y, Nishiwaki T, Kato J, Shinoda N, Sato A, Kimura M, Koyama H, Toyama T et al. 2002 Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Japanese Journal of Clinical Oncology 32 233-237.
87. Solbach C, Roller M, Fellbaum C, Nicoletti M & Kaufmann M 2004 PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence. Breast 13 80-81.
88. Solbach C, Roller M, Peters S, Nicoletti M, Kaufmann M & Knecht R 2005 Pituitary tumor-transforming gene (PTTG): a novel target for anti-tumor therapy. Anticancer Research 25 121-125.
89. Stoika R & Melmed S 2002 Expression and function of pituitary tumour transforming gene for T-lymphocyte activation. British Journal of Haematology 119 1070-1074.
90. Stratford AL, Boelaert K, Tannahill LA, Kim DS, Warfield A, Eggo MC, Gittoes NJ, Young LS, Franklyn JA & McCabe CJ 2005 Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis. Joumal of Clinical Endocrinology and Metabolism 90 4341-4349.
91. Su MC, Hsu HC, Liu YJ & Jeng YM 2006 Overexpression of pituitary tumor-transforming gene-1 in hepatocellular carcinoma. Hepatogastroenterology 53 262-265.
92. Tarabykin V, Britanova O, Fradkov A, Voss A, Katz LS, Lukyanov S & Gruss P 2000 Expression of PTTG and prc1 genes during telencephalic neurogenesis. Mechanisms of Development 92 301-304.
93. Tfelt-Hansen J, Schwarz P, Terwilliger EF, Brown EM & Chattopadhyay N 2003 Calcium-sensing receptor induces messenger ribonucleic acid of human securin, pituitary tumor transforming gene, in rat testicular cancer. Endocrinology 144 5188-5193.
94. Tfelt-Hansen J, Yano S, Bandyopadhyay S, Carroll R, Brown EM & Chattopadhyay N 2004 Expression of pituitary tumor transforming gene (PTTG) and its binding protein in human astrocytes and astrocytoma cells: function and regulation of PTTG in U87 astrocytoma cells. Endocrinology 145 4222-4231.
95. Tfelt-Hansen J, Kanuparthi D & Chattopadhyay N 2006 The emerging role of pituitary tumor transforming gene in tumorigenesis. Clinical Medicine & Research 4 130-137.
96. Thompson AD III & Kakar SS 2005 Insulin and IGF-1 regulate the expression of the pituitary tumor transforming gene (PTTG) in breast tumor cells. FEBS Letters 579 3195-3200.
97. Tong Y, Tan Y, Zhou C & Melmed S 2007 Pituitary tumor transforming gene interacts with SpI to modulate GI/S cell phase transition. Oncogene 26 5596-5605.
98. Tsai SJ, Lin SJ, Cheng YM, Chen HM & Wing LY 2005 Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas. Journal of Clinical Endocrinology and Metabolism 90 3715-3723.
99. Uccella S, Tibiletti MG, Bernasconi B, Finzi G, Oldrini R & Capella C 2005 Aneuploidy, centrosome alteration and securin overexpression as features of pituitary somatotroph and lactotroph adenomas. Analytical and Quantitative Cytology and Histology 27 241-252.
100. Vlotides G, Cruz-Soto M, Rubinek T, Eigler T, Auernhammer CJ & Melmed S 2006 Mechanisms for growth factor-induced pituitary tumor transforming gene-1 expression in pituitary folliculostellate TtT/GF cells. Molecular Endocrinology 20 3321-3335.
101. Vlotides G, Eigler T & Melmed S 2007 Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocrine Reviews 28 165-186.
102. Wang Z & Melmed S 2000a Characterization of the murine pituitary tumor transforming gene (PTTG) and its promoter. Endocrinology 141 763-771.
103. Wang Z & Melmed S 2000b Pituitary tumor transforming gene (PTTG) transforming and transactivation activity. Journal of Biological Chemistry 275 7459-7461.
104. Wang Z, Yu R & Melmed S 2001 Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Molecular Endocrinology 15 1870-1879.
105. Wang Z, Moro E, Kovacs K, Yu R & Melmed S 2003 Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes. PNAS 100 3428-3432.
106. Wang Z, Lu QY, Chen P, Zhang P & Cong YQ 2006 Expression of pituitary tumor-transforming gene in patients with multiple myeloma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14 1143-1145.
107. Wen CY, Nakayama T, Wang AP, Nakashima M, Ding YT, Ito M, Ishibashi H, Matsuu M, Shichijo K & Sekine I 2004 Expression of pituitary tumor transforming gene in human gastric carcinoma. World Journal of Gastroenterology 10 481-493.
108. Wierinckx A, Auger C, Devauchelle P, Reynaud A, Chevallier P, Jan M, Perrin G, Fevre-Montange M, Rey C, Figarella-Branger D et al. 2007 A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocrine-Related Cancer 14 887-900.
109. Winnepenninckx V, Debiec-Rychter M, Belien JA, Fiten P, Michiels S, Lazar V, Opdenakker G, Meijer GA, Spatz A & van den Oord JJ 2006 Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma. Modern Pathology, 19 1170-1180.
110. Xie K, Wei D & Huang S 2006 Transcriptional antiangiogenesis therapy of human pancreatic cancer. Cytokine and Growth Factor Reviews 17 147-156.
111. Yao YQ, Xu JS, Lee WM, Yeung WS & Lee KF 2003 Identification of mRNAs that are up-regulated after fertilization in the murine zygote by suppression subtractive hybridization. Biochemical and Biophysical Research Communications 304 60-66.
112. Yin H, Fujimoto N, Maruyama S & Asano K 2001 Strain difference in regulation of pituitary tumor transforming gene (PTTG) in estrogen- induced pituitary tumorigenesis in rats. Japanese Journal of Cancer Research 92 1034-1040.
113. Yu R, Heaney AP, Lu W, Chen J & Melmed S 2000a Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis. Journal of Biological Chemistry 275 36502-36505.
114. Yu R, Ren SG, Horwitz GA, Wang Z & Melmed S 2000b Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging. Molecular Endocrinology 14 1137-1146.
115. Yu R, Lu W, Chen J, McCabe CJ & Melmed S 2003 Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology 144 4991-4998.
116. Yu R, Cruz-Soto M, Li Calzi S, Hui H & Melmed S 2006 Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells. Journal of Endocrinology 191 45-53.
117. Yuan HQ, Kong F, Wang XL, Young CY, Hu XY & Lou HX 2008 Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of SpI binding activity in prostate cancer cells. Biochemical Pharmacology 75 2112-2121.
118. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD & Melmed S 1999a Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 84 761-767.
119. Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD & Melmed S 1999b Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Molecular Endocrinology 13 156-166.
120. Zhou Y, Mehta KR, Choi AP, Scolavino S & Zhang X 2003 DNA damage-induced inhibition of securin expression is mediated by p53. Journal of Biological Chemistry 278 462-470.
121. Zhou C, Liu S, Zhou X, Xue L, Quan L, Lu N, Zhang G, Bai J, Wang Y, Liu Z et al. 2005 Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin/TCF pathway in human esophageal squamous cell carcinoma. International Journal of Cancer 113 891-898.
122. Zhu X, Mao Z, Na Y, Guo Y, Wang X & Xin D 2006 Significance of pituitary tumor transforming gene 1 (PTTGI) in prostate cancer. Anticancer Research 26 1253-1259.
123. Zou H, McGarry TJ, Bernal T & Kirschner MW 1999 Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285 418-422.